Clinical Trial Update: The Safety and Efficacy of XytriX (Umbilical Cord-Derived Mesenchymal Stem Cells) in the Treatment of Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing safety and efficacy of XytriX, an umbilical cord-derived mesenchymal stem cell product, for knee osteoarthritis; sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• XytriX (Umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: TricelX Inc. | Conditions: Osteoarthritis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING